Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.

Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, Aouizerate J, Matignon M, Rostaing L, Lang P, Grimbert P.

Transpl Int. 2012 May;25(5):e62-6. doi: 10.1111/j.1432-2277.2012.01462.x. Epub 2012 Mar 13.

2.

Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.

Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A.

Artif Organs. 2011 Apr;35(4):420-5. doi: 10.1111/j.1525-1594.2010.01068.x.

PMID:
20637013
3.

Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.

Rodríguez-Ferrero M, Ampuero J, Anaya F.

Transplant Proc. 2009 Jul-Aug;41(6):2406-8. doi: 10.1016/j.transproceed.2009.06.044.

PMID:
19715934
4.

Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.

Chikamoto H, Hattori M, Kuroda N, Kajiho Y, Matsumura H, Fujii H, Ishizuka K, Hisano M, Akioka Y, Nozu K, Kaito H, Shimizu M.

Pediatr Transplant. 2012 Nov;16(7):E286-90. doi: 10.1111/j.1399-3046.2011.01610.x. Epub 2011 Nov 30.

PMID:
22129369
5.

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.

Dall'Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F.

Am J Kidney Dis. 1999 Dec;34(6):1048-55.

PMID:
10585314
6.

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD.

Transplantation. 2009 Apr 27;87(8):1232-9. doi: 10.1097/TP.0b013e31819f12be.

PMID:
19384172
7.

Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.

Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.

Transplantation. 2009 Aug 15;88(3):417-20. doi: 10.1097/TP.0b013e3181aed9d7.

PMID:
19667947
8.

Recurrent focal glomerulosclerosis: natural history and response to therapy.

Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F.

Am J Med. 1992 Apr;92(4):375-83.

PMID:
1558084
9.

Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.

Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M.

Pediatr Transplant. 2011 Aug;15(5):495-501. doi: 10.1111/j.1399-3046.2011.01478.x. Epub 2011 Feb 21.

PMID:
21338460
10.

Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients.

Park HS, Hong Y, Sun IO, Chung BH, Kim HW, Choi BS, Park CW, Jin DC, Kim YS, Yang CW.

Korean J Intern Med. 2014 Jul;29(4):482-8. doi: 10.3904/kjim.2014.29.4.482. Epub 2014 Jun 27.

11.

A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation.

Okamoto M, Koshino K, Sakai K, Nobori S, Matsuyama M, Ushigome H, Okajima H, Masuzawa N, Yoshimura N.

Clin Transplant. 2011 Jul;25 Suppl 23:53-8. doi: 10.1111/j.1399-0012.2011.01455.x.

PMID:
21623916
12.

Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review.

Vinai M, Waber P, Seikaly MG.

Pediatr Transplant. 2010 May;14(3):314-25. doi: 10.1111/j.1399-3046.2009.01261.x. Review.

PMID:
20519016
13.

Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.

Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA, Torres MN.

Pediatr Nephrol. 2010 Mar;25(3):529-34. doi: 10.1007/s00467-009-1361-0. Epub 2009 Dec 3.

PMID:
19956977
14.

Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis.

Moroni G, Gallelli B, Quaglini S, Banfi G, Montagnino G, Messa P.

Transpl Int. 2010 Feb;23(2):208-16. doi: 10.1111/j.1432-2277.2009.00977.x. Epub 2009 Sep 30.

15.

Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.

Matalon A, Markowitz GS, Joseph RE, Cohen DJ, Saal SD, Kaplan B, D'Agati VD, Appel GB.

Clin Nephrol. 2001 Oct;56(4):271-8.

PMID:
11680656
16.

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.

Yabu JM, Ho B, Scandling JD, Vincenti F.

Am J Transplant. 2008 Jan;8(1):222-7. Epub 2007 Nov 2.

17.

Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis.

Stephanian E, Matas AJ, Mauer SM, Chavers B, Nevins T, Kashtan C, Sutherland DE, Gores P, Najarian JS.

Transplantation. 1992 Apr;53(4):755-7.

PMID:
1566339
18.

Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function.

Sener A, Bella AJ, Nguan C, Luke PP, House AA.

Clin Transplant. 2009 Jan-Feb;23(1):96-100. doi: 10.1111/j.1399-0012.2008.00908.x.

PMID:
19200221
19.

Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children.

Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K.

Transplantation. 2001 Mar 15;71(5):628-33.

PMID:
11292291
20.

Early use of plasmapheresis for recurrent post-transplant FSGS.

Pradhan M, Petro J, Palmer J, Meyers K, Baluarte HJ.

Pediatr Nephrol. 2003 Sep;18(9):934-8. Epub 2003 Jun 26.

PMID:
12836097

Supplemental Content

Support Center